JPMorgan Chase & Co. Cuts Position in Leidos Holdings, Inc. $LDOS

JPMorgan Chase & Co. trimmed its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 3.1% in the third quarter, HoldingsChannel.com reports. The fund owned 3,417,810 shares of the aerospace company’s stock after selling 110,820 shares during the period. JPMorgan Chase & Co.’s holdings in Leidos were worth $645,829,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of LDOS. Mather Group LLC. bought a new position in Leidos in the 3rd quarter valued at $28,000. True Wealth Design LLC increased its holdings in Leidos by 471.4% during the second quarter. True Wealth Design LLC now owns 200 shares of the aerospace company’s stock worth $32,000 after buying an additional 165 shares during the last quarter. First Horizon Corp bought a new stake in Leidos in the third quarter worth about $39,000. Mountain Hill Investment Partners Corp. grew its position in shares of Leidos by 66.2% during the 2nd quarter. Mountain Hill Investment Partners Corp. now owns 216 shares of the aerospace company’s stock valued at $34,000 after acquiring an additional 86 shares during the period. Finally, Motco purchased a new stake in shares of Leidos during the 3rd quarter worth approximately $43,000. 76.12% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on LDOS. Cantor Fitzgerald raised their target price on Leidos from $185.00 to $225.00 and gave the stock an “overweight” rating in a research report on Friday, October 31st. Truist Financial restated a “buy” rating and issued a $220.00 price objective (up from $200.00) on shares of Leidos in a research note on Tuesday, November 4th. Zacks Research lowered shares of Leidos from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 23rd. Stifel Nicolaus reissued a “hold” rating and issued a $220.00 price target on shares of Leidos in a research report on Wednesday, January 7th. Finally, UBS Group set a $204.00 price objective on shares of Leidos in a research note on Thursday, January 15th. Nine investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $213.09.

Leidos Trading Down 8.0%

Shares of LDOS opened at $162.18 on Wednesday. Leidos Holdings, Inc. has a 1-year low of $123.62 and a 1-year high of $205.77. The firm has a market capitalization of $20.74 billion, a price-to-earnings ratio of 15.13, a PEG ratio of 1.23 and a beta of 0.59. The firm’s 50-day moving average price is $187.52 and its 200-day moving average price is $186.68. The company has a current ratio of 1.62, a quick ratio of 1.50 and a debt-to-equity ratio of 0.94.

Leidos (NYSE:LDOS) last announced its earnings results on Tuesday, February 17th. The aerospace company reported $2.76 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.19. The firm had revenue of $4.21 billion for the quarter, compared to analysts’ expectations of $4.31 billion. Leidos had a net margin of 8.11% and a return on equity of 33.02%. The company’s quarterly revenue was down 3.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.37 EPS. Leidos has set its FY 2026 guidance at 12.050-12.450 EPS. Sell-side analysts anticipate that Leidos Holdings, Inc. will post 10.62 EPS for the current year.

Leidos Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Monday, March 16th will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Monday, March 16th. Leidos’s dividend payout ratio (DPR) is currently 16.04%.

Key Leidos News

Here are the key news stories impacting Leidos this week:

• Positive Sentiment: Quarterly beat and strong cash flow — Leidos reported non‑GAAP Q4 EPS of $2.76 (above estimates) and highlighted record cash flow and profitable results for FY‑2025, underpinning margin strength. Leidos Posts Strong Fourth Quarter and Fiscal Year 2025 Results
• Positive Sentiment: FY‑2026 guidance raised — Management set EPS guidance of $12.05–$12.45 and revenue guidance above consensus ($17.5–$17.9B), signaling confidence in medium‑term profit growth despite the near‑term revenue hit. Earnings Press Release / Slide Deck
• Positive Sentiment: Strategic M&A to boost energy business — Leidos announced a ~$2.4B acquisition of Entrust to expand its energy footprint as part of the NorthStar 2030 plan, which could drive future revenue diversification. Defense Giant Leidos Delivers Record Cash Flow, Secures $2.4B Acquisition
• Positive Sentiment: Liquidity and capital structure moves — Leidos expanded and extended its revolving credit facility, improving financing flexibility to support the Entrust deal and operations. Leidos Expands and Extends Revolving Credit Facility Agreement
• Positive Sentiment: Dividend maintained/increased shareholder return — Company declared a quarterly dividend, supporting yield and signaling cash return to shareholders. Leidos Reports Strong 2025 Results and Dividend Declaration
• Neutral Sentiment: Co‑investment talks with DoD — Leidos is negotiating co‑investment structures with the Department of Defense on key programs, which could unlock program funding but remains early and uncertain. Leidos Negotiating Co-Investment Deals With DoD For Key Programs
• Neutral Sentiment: Earnings call / detail available — The full Q4 earnings call transcript and slide deck are available for investors who want line‑by‑line color on bookings, backlog and segment trends. Leidos (LDOS) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Revenue miss tied to government shutdown — Q4 revenue of ~$4.21B came in below consensus; management cited the six‑week federal shutdown last year as the primary cause of delayed orders and weaker near‑term revenue. Leidos misses quarterly revenue estimates on government shutdown impact
• Negative Sentiment: Market reaction and investor concern — Coverage notes shares slid after the print as investors focused on the revenue shortfall and what some called a weak near‑term outlook despite record profits. Leidos Stock Slides As Government Shutdown, Weak Outlook Overshadow Record Profits
• Negative Sentiment: Analyst estimates being reworked — Several Wall Street forecasters revised models and price targets ahead of/after the quarter, reflecting uncertainty on timing of government demand recovery. Top Wall Street Forecasters Revamp Leidos Expectations Ahead Of Q4 Earnings

Insider Buying and Selling

In other news, insider Elizabeth A. Porter sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $192.21, for a total transaction of $576,630.00. Following the completion of the transaction, the insider directly owned 38,575 shares of the company’s stock, valued at $7,414,500.75. The trade was a 7.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.69% of the company’s stock.

Leidos Company Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.